PLAYSTUDIOS (MYPS) Competitors $1.06 -0.01 (-0.47%) As of 03:13 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MYPS vs. DH, ECX, WEAV, OSPN, CANG, GCL, PERI, ARQQ, BAND, and BIGCShould you be buying PLAYSTUDIOS stock or one of its competitors? The main competitors of PLAYSTUDIOS include Definitive Healthcare (DH), ECARX (ECX), Weave Communications (WEAV), Onespan (OSPN), Cango (CANG), GCL Global (GCL), Perion Network (PERI), Arqit Quantum (ARQQ), Bandwidth (BAND), and BigCommerce (BIGC). These companies are all part of the "computer software" industry. PLAYSTUDIOS vs. Its Competitors Definitive Healthcare ECARX Weave Communications Onespan Cango GCL Global Perion Network Arqit Quantum Bandwidth BigCommerce PLAYSTUDIOS (NASDAQ:MYPS) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability. Do analysts recommend MYPS or DH? PLAYSTUDIOS currently has a consensus target price of $2.50, suggesting a potential upside of 134.74%. Definitive Healthcare has a consensus target price of $4.90, suggesting a potential upside of 27.14%. Given PLAYSTUDIOS's stronger consensus rating and higher possible upside, equities research analysts plainly believe PLAYSTUDIOS is more favorable than Definitive Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PLAYSTUDIOS 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Definitive Healthcare 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable earnings and valuation, MYPS or DH? PLAYSTUDIOS has higher revenue and earnings than Definitive Healthcare. PLAYSTUDIOS is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPLAYSTUDIOS$261.06M0.51-$28.69M-$0.24-4.44Definitive Healthcare$247.91M2.31-$413.12M-$4.39-0.88 Which has more risk & volatility, MYPS or DH? PLAYSTUDIOS has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Is MYPS or DH more profitable? PLAYSTUDIOS has a net margin of -12.00% compared to Definitive Healthcare's net margin of -206.05%. Definitive Healthcare's return on equity of 3.69% beat PLAYSTUDIOS's return on equity.Company Net Margins Return on Equity Return on Assets PLAYSTUDIOS-12.00% -6.04% -4.71% Definitive Healthcare -206.05%3.69%2.15% Does the media refer more to MYPS or DH? In the previous week, PLAYSTUDIOS had 4 more articles in the media than Definitive Healthcare. MarketBeat recorded 11 mentions for PLAYSTUDIOS and 7 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.09 beat PLAYSTUDIOS's score of -0.21 indicating that Definitive Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PLAYSTUDIOS 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Definitive Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in MYPS or DH? 37.5% of PLAYSTUDIOS shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 14.7% of PLAYSTUDIOS shares are owned by insiders. Comparatively, 16.3% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryPLAYSTUDIOS and Definitive Healthcare tied by winning 8 of the 16 factors compared between the two stocks. Get PLAYSTUDIOS News Delivered to You Automatically Sign up to receive the latest news and ratings for MYPS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MYPS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYPS vs. The Competition Export to ExcelMetricPLAYSTUDIOSGAMING IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$133.21M$9.53B$8.09B$9.68BDividend YieldN/A1.96%3.21%4.14%P/E Ratio-4.4419.1918.7824.95Price / Sales0.5116.824.8577.81Price / Cash3.6520.3116.4358.58Price / Book0.5411.664.485.68Net Income-$28.69M$18.31M$218.18M$265.58M7 Day Performance-2.29%-1.32%0.99%2.52%1 Month Performance-10.50%-3.96%-0.86%1.86%1 Year Performance-32.59%16.81%24.26%24.27% PLAYSTUDIOS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYPSPLAYSTUDIOS2.7597 of 5 stars$1.07-0.5%$2.50+134.7%-30.1%$133.21M$261.06M-4.44510Earnings ReportDHDefinitive Healthcare1.1731 of 5 stars$4.21+2.9%$5.10+21.1%+3.7%$608.69M$252.20M-0.96970News CoverageAnalyst ForecastGap UpECXECARX2.5743 of 5 stars$1.59-0.6%$3.20+101.3%-0.6%$593.17M$761.90M-4.541,918Upcoming EarningsWEAVWeave Communications3.1414 of 5 stars$7.72-0.3%$16.10+108.5%-22.0%$581.91M$204.31M-18.83890Short Interest ↑Gap UpOSPNOnespan4.7563 of 5 stars$15.13+0.4%$19.50+28.9%-15.9%$576.32M$243.18M10.29790News CoveragePositive NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionCANGCango2.5502 of 5 stars$4.98flat$8.00+60.6%+178.6%$516.84M$110.21M-248.882,350GCLGCL GlobalN/A$4.11+0.7%N/AN/A$515.21MN/A0.00N/APERIPerion Network2.2046 of 5 stars$11.20+1.4%$12.38+10.5%+22.6%$495.32M$498.29M-65.88420Positive NewsUpcoming EarningsARQQArqit Quantum1.9117 of 5 stars$36.74-4.1%$52.00+41.5%+319.7%$488.53M$290K0.00140News CoverageShort Interest ↑Gap UpBANDBandwidth4.1067 of 5 stars$16.21+8.1%$20.80+28.3%-11.7%$446.15M$748.49M-46.311,100High Trading VolumeBIGCBigCommerce1.7917 of 5 stars$5.13-0.8%$7.58+47.8%N/A$414.11M$334.94M-19.001,161 Related Companies and Tools Related Companies Definitive Healthcare Alternatives ECARX Alternatives Weave Communications Alternatives Onespan Alternatives Cango Alternatives GCL Global Alternatives Perion Network Alternatives Arqit Quantum Alternatives Bandwidth Alternatives BigCommerce Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MYPS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PLAYSTUDIOS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PLAYSTUDIOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.